NIH-funded research R01 grant

Understanding how chromatin control affects cancer development

Official title: Cancer-based discovery of novel mechanisms of chromatin control

Funded at St. Jude Children's Research Hospital · NIH-11053578 · Data updated 2026-11-12

This study is looking at how certain proteins that help control our genes might cause cancer when they don't work right, especially in a tough childhood cancer called malignant rhabdoid tumor, with the hope of finding better treatments for kids and others affected by cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startApril 6, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$416,325
NIH project number5R01CA273455-03
Project IDNIH-11053578 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include children and young adults diagnosed with cancers linked to SWI/SNF mutations, particularly malignant rhabdoid tumors.

Less likely to help

Patients with cancers not associated with chromatin regulatory mutations may not benefit from this research.

What this research studies

This research investigates the role of chromatin regulatory proteins, particularly the SWI/SNF complexes, in cancer development. By analyzing mutations in these proteins, which are found in over 20% of all cancers, the research aims to uncover how their disruption leads to uncontrolled cell growth and cancer. The study focuses on a specific aggressive childhood cancer, malignant rhabdoid tumor, to explore the mechanisms of oncogenesis and to develop new therapies based on these findings. Patients may benefit from insights that could lead to more effective treatments for various cancers.

Why it matters

Potential benefit: If successful, this research could lead to novel therapies that specifically target cancers associated with chromatin mutations.

How similar studies have gone: Previous research has shown promising results in understanding chromatin mutations in cancer, indicating potential for success in this novel approach.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Roberts, Charles — St. Jude Children's Research Hospital
  • Study coordinator: Roberts, Charles

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.